H.R. 2943 (119th)Bill Overview

Gabriel Rosenberg Dyspraxia/DCD Coverage Act

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Apr 17, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Government Reform, for a period to be subsequently determi…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill directs the Comptroller General (GAO) to study insurance coverage for dyspraxia/developmental coordination disorder (DCD) and report to Congress within one year. The study must assess coverage across Medicare, Medicaid (by State), other Federal health programs, group and individual plans, and the Federal Employees Health Benefits program, identify covered services, age cutoffs, barriers, parity compliance, and provide recommendations, including whether CMS should issue guidance.

Why people may split

Progressive wants faster, stronger coverage action beyond a study

Watch point

Relative to its intended legislative type, this bill is a well-specified study mandate: it assigns the Comptroller General a one-year deadline and enumerates concrete questions to be answered about coverage of dyspraxia/DCD across federal programs, state Medicaid programs, and private insurance.

The bill directs the Comptroller General (GAO) to study insurance coverage for dyspraxia/developmental coordination disorder (DCD) and report to Congress within one year.

The study must assess coverage across Medicare, Medicaid (by State), other Federal health programs, group and individual plans, and the Federal Employees Health Benefits program, identify covered services, age cutoffs, barriers, parity compliance, and provide recommendations, including whether CMS should issue guidance.

Passage60/100

Content is technical, narrow, and nonbinding; such study bills frequently pass or are folded into larger packages, though not guaranteed.

CredibilityAligned

Relative to its intended legislative type, this bill is a well-specified study mandate: it assigns the Comptroller General a one-year deadline and enumerates concrete questions to be answered about coverage of dyspraxia/DCD across federal programs, state Medicaid programs, and private insurance.

Contention32/100

Progressive wants faster, stronger coverage action beyond a study

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesCreates a comprehensive evidence base on coverage gaps across federal, state, and private payers.
  • Potential benefitEnables targeted legislative or regulatory remedies to expand access to DCD therapies and services.
  • Potential benefitCould prompt CMS guidance harmonizing Medicare and Medicaid practices for DCD treatment coverage.
Likely burdened
  • Potential burdenA study produces information but delays immediate policy action to expand coverage.
  • Federal agenciesRequires federal staff time and resources, creating administrative costs for GAO and agencies.
  • Potential burdenRecommendations could lead to new coverage mandates that increase insurers' costs and premiums.
03 · Why people split

Why the argument around this bill splits.

Progressive wants faster, stronger coverage action beyond a study
Progressive80%

Likely supportive because the study addresses a disability-related coverage gap and could lead to improved access.

However, this persona may view a study alone as insufficient and push for concrete coverage requirements or CMS action afterward.

Leans supportive
Centrist85%

Generally favorable as a measured, evidence-gathering step before policy changes.

Sees the GAO study as an appropriate, low-cost way to inform federal and state decisions, while wanting clear cost estimates and practical recommendations.

Leans supportive
Conservative55%

Cautiously supportive of a fact-finding study but wary that it could be a stepping stone to federal mandates and increased costs.

Prefers maintaining state flexibility and avoiding new federal coverage requirements.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood60/100

Content is technical, narrow, and nonbinding; such study bills frequently pass or are folded into larger packages, though not guaranteed.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No cost estimate or appropriations language included
  • GAO workload and prioritization could delay or limit study scope
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressive wants faster, stronger coverage action beyond a study

Content is technical, narrow, and nonbinding; such study bills frequently pass or are folded into larger packages, though not guaranteed.

Unlocked analysis

Relative to its intended legislative type, this bill is a well-specified study mandate: it assigns the Comptroller General a one-year deadline and enumerates concrete questions to be answered about coverage of dyspraxia…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis